Training activity information

Details

Perform and interpret the analyses to laboratory SOPs on patients with:

  • Hyperinsulinaemia  (Insulinoma)
  • GI hormone-secreting tumours (Zollinger-Ellison syndome, carcinoid tumours and rare GI tract tumours)
  • Markers of neuroendocrine tumours (e.g. chromogranins)
  • Prolonged fast (insulin and C-peptide analysis)

Type

Entrustable training activity (ETA)

Evidence requirements

Evidence the activity has been undertaken by the trainee repeatedly, consistently, and effectively over time, in a range of situations. This may include occasions where the trainee has not successfully achieved the outcome of the activity themselves. For example, because it was not appropriate to undertake the task in the circumstances or the trainees recognised their own limitations and sought help or advice to ensure the activity reached an appropriate conclusion. ​

Reflection at multiple timepoints on the trainee learning journey for this activity.

Considerations

  • Local and national training guidelines, including standards and pathways
  • Method selection, including assay advantages and limitations, quality parameters, and interferences
  • Equipment calibration and maintenance
  • Quality control EQA and IQC
  • National and international guidelines
  • Role of the duty biochemist

Relevant learning outcomes

# Outcome
# 2 Outcome

Perform clinical and laboratory investigation, analysis and management of diabetes mellitus.